Performance Comparison of the artus HBV QS-RGQ and the CAP/CTM HBV v2.0 Assays regarding Hepatitis B Virus DNA Quantification

Performance Comparison of the artus HBV QS-RGQ and the CAP/CTM HBV v2.0 Assays regarding Hepatitis B Virus DNA Quantification

Background. Over 240 million people are chronically infected with hepatitis B virus (HBV), the leading cause of liver cancer worldwide. The quantification of the HBV DNA level is critical for monitoring the efficacy of antiviral treatment of chronic HBV patients. Methods. In our study, we compared t...

Full description

Bibliographic Details
Main Authors:	Salma Madihi, Hashim Syed, Fatiha Lazar, Abdelmajid Zyad, Abdelouaheb Benani
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2020/4159189

Similar Items

Comparison of the Amplisure HBV Quantitative Kit with the Qiagen Artus HBV QS-RGQ Assay for Quantifying Viral DNA in Plasma Samples of Monitoring Cases
by: Ganesan Praveenkumar, et al.
Published: (2021-05-01)

A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries
by: Salma Madihi, et al.
Published: (2020-01-01)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
by: Lu Hongzhu, et al.
Published: (2012-03-01)

Quantification of hepatitis B virus (HBV) DNA and HBV genotyping simultaneously in plasma using real-time polymerase chain reaction
by: Woottichai Khamduang, et al.
Published: (2018-08-01)

The roles of HBV viral proteins in HBV persistence: A study using an HBV-persistent mouse model
by: Chun-Ta Lin, et al.
Published: (2015)

Clinical value of anti-HBc quantification for chronic HBV infection
by: HOU Fengqin, et al.
Published: (2018-05-01)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
by: Marcelle Bottecchia, et al.
Published: (2016-03-01)

The study of the competitiveness of CTM : based on CTM branding strategy
by: Wong, San San
Published: (2009)

The impact of HBV/HCV coinfection on HBV DNA levels and the severity of liver diseases in HBV-infected patients undergoing hemodialysis
by: ZHU Fusheng
Published: (2013-02-01)

Development of novel HBV vaccines to overcome nonresponsiveness and studies of immunopathogenic mechanisms of chronic HBV and HBV-associated hepatocellular carcinoma
by: Ho-Yuan Chou, et al.
Published: (2011)

Relationship between e system of hepatitis B and HBV DNA quantification
by: WANG Fei
Published: (2015-04-01)

HBV genome analysis in the progression of HBV related chronic liver disease
by: Ruksana Raihan, et al.
Published: (2017-12-01)

HBV Perinatal Transmission
by: Muhammad Umar, et al.
Published: (2013-01-01)

Occult HBV infection
by: I.A. Zaytsev
Published: (2018-04-01)

Occult HBV infection
by: Mariangela Spinosa, et al.
Published: (2010-09-01)

HBV and HCV Therapy
by: Massimo Colombo, et al.
Published: (2009-10-01)

HBV-Infection and Pregnancy
by: H. Matejko, et al.
Published: (2017-10-01)

Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
by: Huihui Lu, et al.
Published: (2021-08-01)

Investigate the mechanism of BCL6 in HBV clearance and anti-HBV drug screening
by: Yue-Ting Hsieh, et al.
Published: (2017)

The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes
by: Xiao-Mei Song, et al.
Published: (2018-11-01)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
by: Avihingsanon Anchalee, et al.
Published: (2012-03-01)

Artus de Bretaigne : a critical and literary study
by: Spilsbury, Sarah Vivienne
Published: (1973)

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.
by: Z Lee, et al.
Published: (2015-01-01)

HBV‐RNA Co‐amplification May Influence HBV DNA Viral Load Determination
by: Benjamin Maasoumy, et al.
Published: (2020-07-01)

Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication
by: Liu Fang, et al.
Published: (2011-08-01)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
by: Joseph Yoo, et al.
Published: (2018-04-01)

Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons
by: Seyed Moayed Alavian
Published: (2011-10-01)

Phenotypic characterization of a clinical HBV/G isolate relative to a co-infecting HBV/A strain and HBV/A/G recombinant strains
by: Borlang, Jamie Ellen
Published: (2010)

Phenotypic characterization of a clinical HBV/G isolate relative to a co-infecting HBV/A strain and HBV/A/G recombinant strains
by: Borlang, Jamie Ellen
Published: (2010)

Cardiovascular aspects of HBV-infection
by: T. V. Antonova, et al.
Published: (2014-09-01)

LIVER TRANSPLANTATION AND HBV INFECTION
by: O. I. Andreytseva, et al.
Published: (2009-06-01)

INFEZIONE OCCULTA DA HBV
by: A. Bonfà, et al.
Published: (2007-09-01)

Intracellular Trafficking of HBV Particles
by: Bingfu Jiang, et al.
Published: (2020-09-01)

HBV And HCV Molecular Evolution
by: Flor H. Pujol
Published: (2007-02-01)

Occult HBV infection and HCC
by: Isabelle Chemin
Published: (2007-02-01)

Novel Therapies in HBV Infection
by: Giuseppe Foti, et al.
Published: (2019-12-01)

HBV-Specific Adaptive Immunity
by: Adam J. Gehring, et al.
Published: (2009-07-01)

HBV genotypic variability in Cuba.
by: Carmen L Loureiro, et al.
Published: (2015-01-01)

The cytotoxic immune response to HBV
by: O'Rourke, Sara Marie
Published: (1995)

The study of HBV encapsidation signal
by: LI, XIU-LING, et al.
Published: (1992)

Cannot write session to /tmp/vufind_sessions/sess_nda1kplr919d6pep9ms297b54h